Leann Olansky, MD

216.444.6568

Leann Olansky, MD

Appointed: 2006

Leann Olansky, MD
Department: Endocrinology, Diabetes and Metabolism
Location: Cleveland Clinic Main Campus
Mail Code F20
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6568
DeskDesk:216.444.2642
WorkFax:216.445.1656
Leann Olansky, MD
Department: Endocrinology, Diabetes and Metabolism
Location: Stephanie Tubbs Jones Health Center
13944 Euclid Avenue
East Cleveland, OH 44112
WorkAppointment:216.761.4286
DeskDesk:216.767.4242
WorkFax:216.445.1656
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Leann Olansky, MD, is a Staff Physician in the Department of Endocrinology, located on the main campus of Cleveland Clinic. She was appointed in 2006. Dr. Olansky is board-certified in the subspecialty of endocrinology by the American Board of Internal Medicine.

Dr. Olansky's particular interests include diabetes, diabetes complications and glucose sensing technology for management of diabetes.

Professional Highlights

  • Fellow, American College of Endocrinology
  • Fellow, American College of Physicians

Education & Fellowships

Fellowship - University of Virginia Medical Center
Endocrinology
Charlottesville, VA USA
1982
Residency - Georgetown University Hospital
Internal Medicine
Washington, DC USA
1979
Internship - Georgetown University Hospital
Internal Medicine
Washington, DC USA
1977
Medical School - Emory University School of Medicine
Atlanta, GA USA
1976
Graduate - Emory University
Physical Chemistry
Atlanta, GA USA
1976
Undergraduate - Emory University
Atlanta, GA USA
1969

Certifications

  • Internal Medicine
  • Internal Medicine- Endocrinology, Diabetes & Metabolism

Specialty Interests

Type I and Type 2 diabetes, diabetes in pregnancy, diabetic neuropathy, thyroid disease, thyroid nodules, pituitary disease, adrenal disease, calcium disorders, osteoporosis

Awards & Honors

Elected to AOA, Emory University Chapter, 1975

Additional Training

  • Sabbatical: Lab of Alan Permutt, MD, Washington University, Saint Louis, Mo.,1990-1991

Memberships

  • American Diabetes Association
  • Endocrine Society
  • American Association of Clinical Endocrinology
  • American College of Physicians
  • American Society for Bone and Mineral Research

Treatment & Services

  • Diabetes Center
  • Endocrine Immunology
  • General Endocrinology
  • Menstruation
  • Radioactive Iodine Treatment
  • Thyroid Aspiration
  • Thyroid Ultrasound
  • Thyroid Ultrasound And Biopsy

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/31/2013, Dr. Olansky has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Olansky received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Bristol-Myers Squibb
  • Merck & Co., Inc.
  • Takeda Pharmaceuticals North America, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site